Creative Medical Technology Holdings Inc. (CELZ)
$1.11
$0.05
(4.72%)
As on 04-Sep-2026 17:06EDT
Market cap
$7 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.1
-
Face value
--
-
Shares outstanding
6,592,557
10 Years Aggregate
CFO
$-22.11 Mln
EBITDA
$-23.81 Mln
Net Profit
$-65.47 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Creative Medical Technology Holdings (CELZ)
| -43.4 | 69.7 | -49.5 | -66.7 | -37.6 | -61.5 | -72.1 |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Creative Medical Technology Holdings (CELZ)
| -15.2 | -49.6 | 21.0 | -84.1 | -38.2 | -97.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Creative Medical Technology Holdings (CELZ)
|
1.1 | 7.3 | 0.0 | -6.0 | -206,767.7 | -74.7 | -- | 0.8 |
| 86.3 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 270.6 | 17,746.8 | 1,054.4 | 755.9 | 5.7 | -- | 20.9 | 10.5 | |
| 72.7 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 59.0 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 110.2 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 358.2 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 117.4 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 541.1 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 591.3 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 |
Shareholding Pattern
View DetailsAbout Creative Medical Technology Holdings (CELZ)
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers... CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Read more
-
Co-Founder, Chairman, President & CEO
Mr. Timothy Warbington
-
Co-Founder, Chairman, President & CEO
Mr. Timothy Warbington
-
Headquarters
Phoenix, AZ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Creative Medical Technology Holdings (CELZ)
What is the current share price of Creative Medical Technology Holdings Inc (CELZ) Today?
The share price of Creative Medical Technology Holdings Inc (CELZ) is $1.11 (NASDAQ) as of 04-Sep-2026 17:06 EDT. Creative Medical Technology Holdings Inc (CELZ) has given a return of -37.63% in the last 3 years.
What is the current PB & PE ratio of Creative Medical Technology Holdings Inc (CELZ)?
Since, TTM earnings of Creative Medical Technology Holdings Inc (CELZ) is negative, P/E ratio is not available.
The P/B ratio of Creative Medical Technology Holdings Inc (CELZ) is 0.84 times as on 04-Sep-2026, a 84 discount to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.78 |
0.62 |
2024 |
-0.69 |
0.60 |
2023 |
-1.21 |
0.62 |
2022 |
-0.05 |
0.03 |
2021 |
0.07 |
0.14 |
What is the 52 Week High and Low of Creative Medical Technology Holdings Inc (CELZ)?
The 52-week high and low of Creative Medical Technology Holdings Inc (CELZ) are Rs 6.25 and Rs 0.62 as of 07-Sep-2026.
What is the market cap of Creative Medical Technology Holdings Inc (CELZ)?
Creative Medical Technology Holdings Inc (CELZ) has a market capitalisation of $ 7 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Creative Medical Technology Holdings Inc (CELZ)?
Before investing in Creative Medical Technology Holdings Inc (CELZ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.